Oxeia Biopharmaceuticals is a clinical stage biotech company.
Oxeia Biopharmaceuticals has raised $1.5M in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in April 2026.
Oxeia Biopharmaceuticals's investors include TCA Venture Group.
Oxeia Biopharmaceuticals is headquartered in San Diego, United States.
Oxeia Biopharmaceuticals is a clinical stage biotech company.
Oxeia Biopharmaceuticals is at the Equity Crowdfunding stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Oxeia Biopharmaceuticals — Funding & Investors." VCBacked, April 7, 2026, https://www.vcbacked.co/company/oxeia-biopharmaceuticals. Accessed October 17, 2026.
VCBacked. (2026). Oxeia Biopharmaceuticals — Funding & Investors. Retrieved October 17, 2026, from https://www.vcbacked.co/company/oxeia-biopharmaceuticals
{{cite web |title=Oxeia Biopharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/oxeia-biopharmaceuticals |website=VCBacked |access-date=October 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated